Literature DB >> 18753412

Calreticulin enhances porcine wound repair by diverse biological effects.

Lillian B Nanney1, Christopher D Woodrell, Mathew R Greives, Nancy L Cardwell, Alonda C Pollins, Tara A Bancroft, Adrianne Chesser, Marek Michalak, Mohammad Rahman, John W Siebert, Leslie I Gold.   

Abstract

Extracellular functions of the endoplasmic reticulum chaperone protein calreticulin (CRT) are emerging. Here we show novel roles for exogenous CRT in both cutaneous wound healing and diverse processes associated with repair. Compared with platelet-derived growth factor-BB-treated controls, topical application of CRT to porcine excisional wounds enhanced the rate of wound re-epithelialization. In both normal and steroid-impaired pigs, CRT increased granulation tissue formation. Immunohistochemical analyses of the wounds 5 and 10 days after injury revealed marked up-regulation of transforming growth factor-beta3 (a key regulator of wound healing), a threefold increase in macrophage influx, and an increase in the cellular proliferation of basal keratinocytes of the new epidermis and of cells of the neodermis. In vitro studies confirmed that CRT induced a greater than twofold increase in the cellular proliferation of primary human keratinocytes, fibroblasts, and microvascular endothelial cells (with 100 pg/ml, 100 ng/ml, and 1.0 pg/ml, respectively). Moreover, using a scratch plate assay, CRT maximally induced the cellular migration of keratinocytes and fibroblasts (with 10 pg/ml and 1 ng/ml, respectively). In addition, CRT induced concentration-dependent migration of keratinocytes, fibroblasts macrophages, and monocytes in chamber assays. These in vitro bioactivities provide mechanistic support for the positive biological effects of CRT observed on both the epidermis and dermis of wounds in vivo, underscoring a significant role for CRT in the repair of cutaneous wounds.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18753412      PMCID: PMC2527067          DOI: 10.2353/ajpath.2008.071027

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  82 in total

Review 1.  Cutaneous wound healing.

Authors:  A J Singer; R A Clark
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

Review 2.  Emerging new drugs for wound repair.

Authors:  Karen Meier; Lillian B Nanney
Journal:  Expert Opin Emerg Drugs       Date:  2006-03       Impact factor: 4.191

Review 3.  Chaperonopathies by defect, excess, or mistake.

Authors:  Alberto J L Macario; Everly Conway de Macario
Journal:  Ann N Y Acad Sci       Date:  2007-05-04       Impact factor: 5.691

4.  Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds.

Authors:  G F Pierce; J Vande Berg; R Rudolph; J Tarpley; T A Mustoe
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

Review 5.  Cellular functions of endoplasmic reticulum chaperones calreticulin, calnexin, and ERp57.

Authors:  Karen Bedard; Eva Szabo; Marek Michalak; Michal Opas
Journal:  Int Rev Cytol       Date:  2005

6.  Thrombospondin mediates focal adhesion disassembly through interactions with cell surface calreticulin.

Authors:  S Goicoechea; A W Orr; M A Pallero; P Eggleton; J E Murphy-Ullrich
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

7.  Modulation of porcine wound repair with a transfected ErbB3 gene and relevant EGF-like ligands.

Authors:  Martina I Okwueze; Nancy L Cardwell; Alonda C Pollins; Lillian B Nanney
Journal:  J Invest Dermatol       Date:  2006-11-23       Impact factor: 8.551

8.  Impaired p53 expression, function, and nuclear localization in calreticulin-deficient cells.

Authors:  Nasrin Mesaeli; Clark Phillipson
Journal:  Mol Biol Cell       Date:  2004-02-06       Impact factor: 4.138

Review 9.  Wounds: an overview of the role of oxygen.

Authors:  Harriet W Hopf; Mark D Rollins
Journal:  Antioxid Redox Signal       Date:  2007-08       Impact factor: 8.401

10.  Hypoxia-inducible factor-1 transactivates transforming growth factor-beta3 in trophoblast.

Authors:  Hirotaka Nishi; Toshihide Nakada; Mitsuyasu Hokamura; Yumi Osakabe; Osamu Itokazu; L Eric Huang; Keiichi Isaka
Journal:  Endocrinology       Date:  2004-05-20       Impact factor: 4.736

View more
  35 in total

Review 1.  The role of the endoplasmic reticulum protein calreticulin in mediating TGF-β-stimulated extracellular matrix production in fibrotic disease.

Authors:  Benjamin Y Owusu; Kurt A Zimmerman; Joanne E Murphy-Ullrich
Journal:  J Cell Commun Signal       Date:  2017-10-28       Impact factor: 5.782

2.  Calreticulin Regulates Neointima Formation and Collagen Deposition following Carotid Artery Ligation.

Authors:  Kurt A Zimmerman; Dongqi Xing; Manuel A Pallero; Ailing Lu; Masahito Ikawa; Leland Black; Kenneth L Hoyt; Janusz H Kabarowski; Marek Michalak; Joanne E Murphy-Ullrich
Journal:  J Vasc Res       Date:  2016-02-25       Impact factor: 1.934

3.  Changes in tumor growth and metastatic capacities of J82 human bladder cancer cells suppressed by down-regulation of calreticulin expression.

Authors:  Yi-Chien Lu; Chiung-Nien Chen; Bojeng Wang; Wen-Ming Hsu; Szu-Ta Chen; King-Jen Chang; Cheng-Chi Chang; Hsinyu Lee
Journal:  Am J Pathol       Date:  2011-06-30       Impact factor: 4.307

4.  Thrombospondin 1 and Its Diverse Roles as a Regulator of Extracellular Matrix in Fibrotic Disease.

Authors:  Joanne E Murphy-Ullrich
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

5.  A View of the Endoplasmic Reticulum Through the Calreticulin Lens.

Authors:  Luis B Agellon; Marek Michalak
Journal:  Prog Mol Subcell Biol       Date:  2021

6.  Amblyomma americanum tick calreticulin binds C1q but does not inhibit activation of the classical complement cascade.

Authors:  Tae Kwon Kim; Adriana Mércia Guaratini Ibelli; Albert Mulenga
Journal:  Ticks Tick Borne Dis       Date:  2015-02       Impact factor: 3.744

Review 7.  Unfolding the Role of Calreticulin in Myeloproliferative Neoplasm Pathogenesis.

Authors:  Ross L Levine; Elodie Pronier; Tiffany R Merlinsky
Journal:  Clin Cancer Res       Date:  2019-01-17       Impact factor: 12.531

8.  Small cytoskeleton-associated molecule, fibroblast growth factor receptor 1 oncogene partner 2/wound inducible transcript-3.0 (FGFR1OP2/wit3.0), facilitates fibroblast-driven wound closure.

Authors:  Audrey Lin; Akishige Hokugo; Jae Choi; Ichiro Nishimura
Journal:  Am J Pathol       Date:  2009-12-03       Impact factor: 4.307

9.  Genomics and proteomics approaches to the study of cancer-stroma interactions.

Authors:  Flávia C Rodrigues-Lisoni; Paulo Peitl; Alessandra Vidotto; Giovana M Polachini; José V Maniglia; Juliana Carmona-Raphe; Bianca R Cunha; Tiago Henrique; Caique F Souza; Rodrigo A P Teixeira; Erica E Fukuyama; Pedro Michaluart; Marcos B de Carvalho; Sonia M Oliani; Eloiza H Tajara; P M Cury; M B de Carvalho; E Dias-Neto; D L A Figueiredo; E E Fukuyama; J F Góis-Filho; A M Leopoldino; R C M Mamede; P Michaluart-Junior; R A Moyses; F G Nóbrega; M P Nóbrega; F D Nunes; E F B Ojopi; L N Serafini; P Severino; A M A Silva; W A Silva; N J F Silveira; S C O M Souza; E H Tajara; V Wünsch-Filho; A Amar; C M Bandeira; M A Braconi; L G Brandão; R M Brandão; A L Canto; M Cerione; R Cicco; M J Chagas; H Chedid; A Costa; B R Cunha; O A Curioni; C S Fortes; S A Franzi; A P Z Frizzera; D Gazito; P E M Guimarães; C M Kaneto; R V M López; R Macarenco; M R Magalhães; C Meneses; A M C Mercante; D G Pinheiro; G M Polachini; A Rapoport; C O Rodini; F C Rodrigues-Lisoni; R V Rodrigues; L Rossi; A R D Santos; M Santos; F Settani; F A M Silva; I T Silva; T B Souza; E Stabenow; J T Takamori; P J Valentim; A Vidotto; F C A Xavier; F Yamagushi; M L Cominato; P M S Correa; G S Mendes; R Paiva; O Ramos; C Silva; M J Silva; M V C Tarlá
Journal:  BMC Med Genomics       Date:  2010-05-04       Impact factor: 3.063

Review 10.  Calreticulin: non-endoplasmic reticulum functions in physiology and disease.

Authors:  Leslie I Gold; Paul Eggleton; Mariya T Sweetwyne; Lauren B Van Duyn; Matthew R Greives; Sara-Megumi Naylor; Marek Michalak; Joanne E Murphy-Ullrich
Journal:  FASEB J       Date:  2009-11-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.